Clinical Trial Update: Elobixibat Colonic Motor Function Study [Phase 2]

View source ↗

Summary

The Phase 2 trial of elobixibat for chronic idiopathic constipation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• Elobixibat (elobixibat)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Chronic Idiopathic Constipation | Phase 2 | Status: WITHDRAWN